Physician profile
Orlando Rivera
NPI 1720016827
$383,636.03
in general payments reported to CMS, 2019-2025
22 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $33.87 · 2021: $32.32 · 2022: $325K · 2023: $37K · 2024: $21K · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $44K · Debt Forgiveness: $12K · Food and Beverage: $1,279 · Travel and Lodging: $588 · Education: $78.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $43,717.35 |
| Debt Forgiveness | $12,200.00 |
| Food and Beverage | $1,278.91 |
| Travel and Lodging | $588.02 |
| Education | $78.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $368,189.34 | 2022-2024 | Avenger Radial Head, +4 Stems |
| Skye Orthobiologics LLC | $12,200.00 | 2024 | |
| Treace Medical Concepts, INC. | $1,158.86 | 2022-2025 | |
| In2bones USA, LLC | $1,000.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $216.64 | 2023-2025 | Nuzyra |
| Vaporox, INC. | $135.56 | 2023 | Vht-200 Wound Treatment System |
| Allergan, INC. | $126.24 | 2019 | |
| Abbott Laboratories | $119.21 | 2023-2024 | Diamondback Peripheral, Proclaim |
| Stryker Corporation | $78.47 | 2025 | Fixos, Augment Injectable, Anchorage |
| Theramicro, INC. | $57.25 | 2025 | Centavisc, Stemnios, Tekbrace Solo |
| Abbvie INC. | $56.18 | 2023 | Dalvance |
| Organogenesis INC. | $43.61 | 2023 | Puraply |
| Kowa Pharmaceuticals America, INC. | $42.08 | 2022-2023 | Seglentis |
| Smith+Nephew, INC. | $39.71 | 2022-2024 | Collagenase Santyl |
| Pfizer INC. | $33.87 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $30.01 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Heron Therapeutics, INC. | $20.39 | 2023 | Zynrelef |
| Horizon Therapeutics Plc | $20.27 | 2023 | Krystexxa |
| Nevro Corp. | $19.73 | 2022 | |
| Sebela Pharmaceuticals INC. | $17.79 | 2021 | |
| Convatec INC. | $16.29 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $14.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orlando Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.